GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Telecomunicacoes De Sao Paulo S.a. (VIV) [hlAlert]

Rating:
Buy VIV
down 37.73 %

Telecomunicacoes de Sao Paulo S/A ADS (VIV) rated Buy with price target $24 by Standpoint Research

Posted on: Monday,  Mar 3, 2014  1:25 PM ET by Standpoint Research

Standpoint Research rated Buy Telecomunicacoes de Sao Paulo S/A ADS (NYSE: VIV) on 03/03/2014, when the stock price was $18.47.
Since then, Telecomunicacoes de Sao Paulo S/A ADS has lost 37.74% as of 10/06/2015's recent price of $11.50.
If you would have followed this Standpoint Research's recommendation on VIV, you would have lost 37.73% of your investment in 582 days.

Vivo Participacoes SA (Vivo) is a Brazil-based company engaged in providing cellular telecommunications services. The Company has 100% interest in Vivo S.A., a provider of mobile telephone services in the states of, Acre, Alagoas, Amapa, Amazonas, Bahia, Ceara, Espirito Santo, Goias, Maranhao, Mato Grosso, Mato Grosso do Sul, Para, Paraiba, Parana, Pernambuco, Piaui, Rio de Janeiro, Rio Grande do Sul, Rondonia, Roraima, Santa Catarina, Sao Paulo, Sergipe, Tocantins and Minas Gerais through its subsidiary Telemig Celular. Vivo is controlled by Brasilcel N.V. (Brasilcel), a joint venture between Portugal Telecom and Telefonica. On April 03, 2008, it acquired Telemig Celular S.A., a wireless telecommunication provider in the state of Minas Gerais.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/11/2011 12:25 PM Hold
None
26.80
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD up  7.28 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2011 10:25 AM Buy
None
24.98 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy